These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16624952)

  • 1. Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism.
    Jiang Q; Yan Z; Feng J
    J Neurosci; 2006 Apr; 26(16):4318-28. PubMed ID: 16624952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons.
    Jiang Q; Yan Z; Feng J
    J Biol Chem; 2006 Sep; 281(39):29391-400. PubMed ID: 16887804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism.
    Ren Y; Feng J
    J Neurochem; 2007 Oct; 103(1):303-11. PubMed ID: 17587308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation.
    Ren Y; Jiang H; Yang F; Nakaso K; Feng J
    J Biol Chem; 2009 Feb; 284(6):4009-17. PubMed ID: 19074146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective vulnerability of dopaminergic neurons to microtubule depolymerization.
    Ren Y; Liu W; Jiang H; Jiang Q; Feng J
    J Biol Chem; 2005 Oct; 280(40):34105-12. PubMed ID: 16091364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
    Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
    Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
    Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
    Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
    Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.
    Ahmadi FA; Linseman DA; Grammatopoulos TN; Jones SM; Bouchard RJ; Freed CR; Heidenreich KA; Zawada WM
    J Neurochem; 2003 Nov; 87(4):914-21. PubMed ID: 14622122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.
    Meinel J; Radad K; Rausch WD; Reichmann H; Gille G
    Folia Neuropathol; 2015; 53(1):29-40. PubMed ID: 25909873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of toxicity in rotenone models of Parkinson's disease.
    Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
    J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
    Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
    Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death.
    Choi WS; Kim HW; Xia Z
    Toxicology; 2015 Feb; 328():75-81. PubMed ID: 25496994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease.
    Calandria JM; Sharp MW; Bazan NG
    Cell Mol Neurobiol; 2015 Nov; 35(8):1127-36. PubMed ID: 26047923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways.
    Hsuan SL; Klintworth HM; Xia Z
    J Neurosci; 2006 Apr; 26(17):4481-91. PubMed ID: 16641227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the nigrostriatal pathway by metabotropic glutamate receptors during development.
    Plenz D; Kitai ST
    J Neurosci; 1998 Jun; 18(11):4133-44. PubMed ID: 9592093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.